| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCI | Common Stock | Sale | -$558K | -9.96K | -22.21% | $55.97 | 34.9K | May 22, 2023 | Direct | F1, F2 |
| transaction | HCI | Common Stock | Sale | -$284K | -5.04K | -10.37% | $56.38 | 43.5K | May 19, 2023 | Direct | F1, F3 |
| transaction | HCI | Common Stock | Tax liability | -$11.9K | -213 | -100% | $55.66 | 0 | May 20, 2023 | Direct | F4, F5 |
| transaction | HCI | Common Stock | Tax liability | -$11.8K | -212 | -19.5% | $55.66 | 875 | May 20, 2023 | Direct | F6, F7 |
| holding | HCI | Common Stock | 1.5K | May 19, 2023 | Direct | F8 | |||||
| holding | HCI | Common Stock | 34K | May 19, 2023 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | The reporting person is seeking to improve modestly the diversification of his investment holdings. |
| F2 | The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.75 to $57.160 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F3 | The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.00 to $57.285 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F4 | 213 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 875 restricted shares on May 20, 2023. |
| F5 | Restricted stock grant of 3,500 shares effective 6/14/2019: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2020, May 20, 2021, May 20, 2022, and May 20, 2023. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/14/2019. |
| F6 | 212 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 875 restricted shares on May 20, 2023. |
| F7 | Restricted stock grant of 3,500 shares effective 5/26/2020: Restriction period will lapse and the restricted shares will vest as follows: 875 shares on each of May 20, 2021, May 20, 2022, May 20, 2023, and May 20, 2024. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/26/2020. |
| F8 | Restricted stock grant of 3,000 shares effective 2/26/2021: Restriction period will lapse and the restricted shares will vest as follows: 750 shares on each of February 26, 2022, February 26, 2023, February 26, 2024, and February 26, 2025. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021. |
| F9 | Restricted stock grant of 34,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021. |